Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.280
-0.070 (-5.19%)
At close: Aug 24, 2026, 4:00 PM EDT
1.310
+0.030 (2.34%)
Pre-market: Aug 25, 2026, 5:27 AM EDT
PACB Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $3 | Buy | Reiterates | $3 | +134.38% | Aug 17, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2 | Hold | Reiterates | $2 | +56.25% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $3 | Buy | Maintains | $3 | +134.38% | Aug 6, 2026 |
| Barclays | Barclays | Sell Reiterates $1 → $1.5 | Sell | Reiterates | $1 → $1.5 | +17.19% | May 11, 2026 |